Pharmaceutical Supply – FLUOROMETHOLONE OPH (Topical Ophthalmic Steroid)

The contract involves the manufacture and supply of eight bottles of Fluorometholone Ophthalmic Suspension, identified by NSN 6505010153995, to meet stringent FDA current Good Manufacturing Practices and military-specific labeling requirements. The product is a topical ophthalmic steroid intended for military use and must comply with all regulatory and technical standards mandated for defense medical supplies. Delivery is designated for Fort Bragg, North Carolina, ensuring alignment with operational medical needs at the installation. This action is classified as a subcontract under the North American Industry Classification System code 325412, which corresponds to pharmaceutical and medicine manufacturing. The contract is managed by the Defense Logistics Agency on behalf of the Department of Defense, reflecting its role in securing critical pharmaceutical inventory for military personnel. The posting date of July 20, 2026, indicates this is a future procurement, likely planned for procurement cycle alignment or inventory replenishment. The contract details are accessible through the DIBBS system, and while no specific point of contact or funding details are provided, adherence to military logistics protocols and pharmaceutical compliance is mandatory.